Skip to content

Post operative pain management with scalp block using ropivacaine and ropivacaine plus clonidine in craniotomy surgeries

Comparison of effect of scalp block with ropivacine vs ropivacaine plus clonidine on post operative pain in patients undergoing craniotomy surgery under general anaesthesia. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059907
Enrollment
60
Registered
2023-11-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: GROUP B: scalp block will be given to patients undergoing craniotomy with 20ml 0.5% Ropivacaine and 1µ/kg Clonidine +0.5ml normal saline total 21cc before incision Control Intervention1

Sponsors

Dr. Abhishek Raj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1 & 2 GCS 15/15, scheduled for supratentorial craniotomies surgery duration lasting less than 360 minutes

Exclusion criteria

Exclusion criteria: Emergency cases patients with uncontrolled hypertension or preoperative bradycardia IHD or cardiac arrhythmias chronic alcoholism and chronic drug abusers Past history of craniotomy Drug allergy to local anaesthetics and or clonidine Patient refusal

Design outcomes

Primary

MeasureTime frame
intraoperative & postoperative analgesics requirement will be reduced.Timepoint: intraop 5min 15min 30min 60min 90min 120min Heart rate & BP postop 30min 60min 120min 180min 240min 8hrs 12hrs 1 recording 6hrs 20hrs 24hrs pain score and analgesic requirement

Secondary

MeasureTime frame
post op pain reliefTimepoint: postop 30min 60min 120min 180min 240min 8hrs 12hrs 16hrs 20hrs 24hrs

Countries

India

Contacts

Public ContactDr Aparna Bagle

Dr. D. Y. Patil medical college, hospital and research centre, Sant Tukaram Nagar, Pimpri, Pune

draparnabagle@gmail.com09422710943

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026